Ling, Junhong et al. published their research in Journal of Pharmaceutical Sciences (Philadelphia, PA, United States) in 2019 |CAS: 86393-32-0

The Article related to antibiotic ciprofloxacin colistin inhalation powder formulation jet milling, aerosol performance, dry powder inhaler, jet milling, mixing, uniformity, Pharmaceuticals: Formulation and Compounding and other aspects.Related Products of 86393-32-0

On September 30, 2019, Ling, Junhong; Mangal, Sharad; Park, Heejun; Wang, Shaoning; Cavallaro, Alex; Zhou, Qi Tony published an article.Related Products of 86393-32-0 The title of the article was Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling. And the article contained the following:

Homogeneous mixing of 2 cohesive jet-milled drug powders is a challenge for pharmaceutical manufacturing on account of their cohesive nature resulting in the formation of strong and random agglomerates. In this study, colistin and ciprofloxacin were co-jet milled to develop combinational antibiotic dry powder formulations for inhalation. The properties of particle size, morphol., content uniformity, and in vitro aerosolization were evaluated. The distribution of 2 drugs in the co-jet milled powders was assessed using time-of-flight-secondary ion mass spectrometry. The co-jet milled powders demonstrated an acceptable content uniformity indicating homogeneity. In general, time-of-flight-secondary ion mass spectrometry images showed relatively homogeneous distributions of ciprofloxacin and colistin in the co-milled formulations. Importantly, the 2 drugs generally had the similar fine particle fraction and deposition behavior in each combinational formulation supporting that the particle mixtures were relatively homogenous and could maximize the antimicrobial synergy. In conclusion, co-jet milling could be a viable technique to produce the combination powders for inhalation. The experimental process involved the reaction of 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate(cas: 86393-32-0).Related Products of 86393-32-0

The Article related to antibiotic ciprofloxacin colistin inhalation powder formulation jet milling, aerosol performance, dry powder inhaler, jet milling, mixing, uniformity, Pharmaceuticals: Formulation and Compounding and other aspects.Related Products of 86393-32-0

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics